<DOC>
	<DOCNO>NCT01375738</DOCNO>
	<brief_summary>This study investigate effect gastrectomy remission type 2 diabetes patient gastric cancer type 2 diabetes , investigate mechanism blood glucose alteration intestinal hormonal signal reconstruction method , evaluate applicability efficacy Roux-en-Y gastrojejunostomy gastrectomy gastric cancer patient diabetes .</brief_summary>
	<brief_title>Improving Diabetes Reconstruction Methods Gastric Cancer Patients With Diabetes Mellitus</brief_title>
	<detailed_description>Purpose : - To investigate effect gastrectomy remission type 2 diabetes patient gastric cancer type 2 diabetes - To investigate mechanism blood glucose alteration intestinal hormonal signal reconstruction method - To evaluate applicability efficacy Roux-en-Y gastrojejunostomy gastrectomy gastric cancer patient diabetes Contents : - Evaluation status diabetes gastric cancer patient DM gastrectomy - Comparison two reconstruction type gastrectomy Bypass duodenum upper jejunum : Roux-en-Y gastrojejunostomy Preservation duodenal passage : Gastroduodenostomy - Analysis biochemical marker reflect diabetic status : fasting glucose , postprandial 2h glucose , HbA1c , C-peptide , lipid profile - Correlation parameter associate diabetes GI hormone - Measurement GI hormone effect glucose tolerance - Insulin , glucagon , IGF-1 , GLP-1 , Neuropeptide Y , Ghrelin , Leptin - Correlation reconstruction method , parameter diabetes GI hormone level - Evaluation mechanism Roux-en-Y gastrojejunostomy control diabetes - Evaluation Feasibility Roux-en-Y gastrojejunostomy gastric cancer surgery patient DM - Degree high blood glucose control , amount antidiabetic medication , cost DM treatment , quality life assessment - Analysis mechanism gastrointestinal physiology diabetes control</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Patient old 20 year younger 80 year Histologically confirm gastric adenocarcinoma locate low one third stomach Postoperative confirm pT1N0 , pT2N0 , pT1N1 Informed consent Previous history treatment malignancy inflammatory disease Preoperative uncontrolled serious comorbidity Vulnerable Subjects ( pregnant woman , child , cognitively impaired person etc . ) Patient experience complication require reoperation follow gastrectomy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Early gastric cancer</keyword>
</DOC>